Alberto Grandi

This inventor holds 6 USPTO granted patents and 10 published patent applications and 7 EPO patents. Top assignees: Biomvis Srl, Externautics S.p.a.. Active years: 2014-2026.

USPTO Granted Patents = 6 (Patent Applications = 10)

% Patents Active = 50.0

EPO Patents = 7 (Patent Applications = 20)

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 2(Granted Patents)

Company Filing History:

Years Active: 2014-2026

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12551544 - METHOD FOR THE PRODUCTION OF OUTER MEMBRANE VESICLES AND IMMUNOGENIC COMPOSITIONS THEREOF (2026-02-17),

2. 12054521 - FhuD2 fusion proteins for the outer membrane vesicle (OMV) delivery of heterologous polypetides and immunogenic compositions thereof (2024-08-06),

3. 11066453 - Immunogenic compositions containing bacterial outer membrane vesicles and therapeutic uses thereof (2021-07-20),

4. 10359428 - Tumor marker, monoclonal antibodies and methods of use thereof (2019-07-23),

5. 10288617 - Ovary tumor markers and methods of use thereof (2019-05-14),

6. 8921058 - Prostate tumor markers and methods of use thereof (2014-12-30),

Title: The Innovative Contributions of Alberto Grandi

Introduction

Alberto Grandi is a notable inventor based in Siena, Italy. He has made significant contributions to the field of biotechnology, particularly in the development of immunogenic compositions and fusion proteins. With a total of five patents to his name, Grandi's work has the potential to impact cancer treatment and immunology.

Latest Patents

Grandi's latest patents include innovative technologies such as FhuD2 fusion proteins for the outer membrane vesicle (OMV) delivery of heterologous polypeptides and immunogenic compositions. These fusion proteins comprise the bacterial protein FhuD2 and one or more copies of a heterologous polypeptide. The patents also cover polynucleotides and expression vectors encoding these fusion proteins, as well as bacterial outer membrane vesicles containing them. Another significant aspect of his work involves immunogenic compositions that utilize bacterial outer membrane vesicles loaded with tumor antigens. These compositions aim to stimulate an immune response against tumors, providing new avenues for prevention and treatment.

Career Highlights

Throughout his career, Grandi has worked with various companies, including Externautics S.p.a. and Biomvis Srl. His expertise in biotechnology and immunology has allowed him to contribute to groundbreaking research and development in these organizations.

Collaborations

Grandi has collaborated with notable colleagues such as Renata Grifantini and Piero Pileri. These partnerships have further enhanced his research and innovation in the field.

Conclusion

Alberto Grandi's contributions to biotechnology and immunology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in cancer treatment and immunogenic therapies.